According to a recent survey conducted by Dechert LLP, securities fraud class action lawsuits against publicly traded life sciences companies are on the rise. They published the findings of their survey in a seven page report titled Publicly Traded Life Sciences Companies in the United States Remain an Increasingly Popular Target of Securities Fraud Class Action Lawsuits.
In their survey, they determined 28 lawsuits were filed in 2012 against life sciences companies, up 9% from the previous year. They cite different cases and the nature of the claims. Dechert concludes there could be more such lawsuits in the future because the Supreme Court recently lowered the standard for plaintiffs seeking class certification.
Dechert LLP is an international firm with offices in the United States, Europe, Asia, and the Middle East. Their practice areas include mergers and acquisitions, corporate finance, and white collar defense.


According to various 

According to





